Abstract
International travel is increasing. As fungal infections associated with travel are rare diseases, they are often underestimated and misdiagnosed. Thus, updated knowledge in this area is of key importance for physicians not only for pretravel counselling but also for the management of patients upon their return. We present an update of data published in 2012 and 2013. We present an overview of epidemiological changes, especially new endemic areas, and the implications of climate and natural disasters. Through experimental and clinical data, new insights into the pathophysiology of fungal infections associated with travel have been obtained, especially for Cryptococcus spp. Recently published diagnostic tools could lead to faster and more accurate diagnosis. Lastly, recent prognostic and therapeutic data are emphasized.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• United Nations World Tourism Organization. Tourism Highlights, 2013 Edition. http://mkt.unwto.org/en/publication/unwto-tourism-highlights-2013-edition. Very informative about tourism data.
•• Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis. 2012;56(6):861–9. Review about immunocompromised traveler with useful diagnostic scheme.
• Leder K, Torresi J, Libman MD, et al. GeoSentinel surveillance of illness in returned travelers, 2007–2011. Ann Intern Med. 2013;158(6):456–68. Study with some recruitment bias but which provides information about ill returning travellers.
• Meece JK, Anderson JL, Gruszka S, Sloss BL, Sullivan B, Reed KD. Variation in clinical phenotype of human infection among genetic groups of Blastomyces dermatitidis. J Infect Dis. 2013;207(5):814–22. Advances in research on virulence mechanisms in fungi.
• Chang P, Rodas C. Skin lesions in histoplasmosis. Clin Dermatol. 2012;30(6):592–8. Dermatological aspects of histoplasmosis.
•• Byrnes 3rd EJ, Li W, Ren P, et al. A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog. 2013;7(9):e1002205. A seminal study on pathogeny of C. gattii.
•• Chen SC, Korman TM, Slavin MA, et al. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis. 2013;57(4):543–51. Very informative study of the demographics, clinical data, outcome and treatment of C. gattii.
•• Chen SC, Slavin MA, Heath CH, et al. Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis. 2012;55(6):789–98. Very informative study of the demographics, clinical data, outcome and treatment of C. gattii.
Vikram HR, Smilack JD, Leighton JA, Crowell MD, De Petris G. Emergence of gastrointestinal basidiobolomycosis in the United States, with a review of worldwide cases. Clin Infect Dis. 2012;54(12):1685–91.
Theodoro RC, Teixeira MM, Felipe MS, et al. Genus paracoccidioides: species recognition and biogeographic aspects. PLoS One. 2012;7(5):e37694.
•• Fisher MC, Henk DA, Briggs CJ, et al. Emerging fungal threats to animal, plant and ecosystem health. Nature. 2012;484(7393):186–94. Very comprehensive review on interactions between fungal disease and ecosystems.
• Systemic mycoses. Clin Dermatol. 2012;30(6):563–684. doi:10.1016/S0738-081X(12)00195-2. Special issue on dermatological involvement in deep mycosis.
• Subcutaneous mycoses. Clin Dermatol. 2012;30(4):367–468. doi:10.1016/S0738-081X(12)00088-0. Special issue on dermatological involvement in superficial mycosis.
• Smith JA, Kauffman CA. Pulmonary fungal infections. Respirology. 2012;17(6):913–26.
Romeo O, Scordino F, Chillemi V, Criseo G. Cryptococcus neoformans/Cryptococcus gattii species complex in southern Italy: an overview on the environmental diffusion of serotypes, genotypes and mating-types. Mycopathologia. 2012;174(4):283–91.
•• Hagen F, Colom MF, Swinne D, et al. Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis. 2012;18(10):1618–24. Comprehensive study about C. gattii infection in Europe and evidence of autochtonous strains.
Permpalung N, Kaewpoowat Q, Prasidthrathsint K, Chongnarungsin D, Hyman CL. Pulmonary blastomycosis: a new endemic area in New York state. Mycoses. 2013. doi:10.1111/myc.12073.
Litvinov IV, St-Germain G, Pelletier R, Paradis M, Sheppard DC. Endemic human blastomycosis in Quebec, Canada, 1988–2011. Epidemiol Infect. 2013;141(6):1143–7.
Centers for Disease Control and Prevention (CDC). Increase in reported coccidioidomycosis – United States, 1998–2011. MMWR Morb Mortal Wkly Rep. 2013;62(12):217–21.
Marsden-Haug N, Goldoft M, Ralston C, et al. Coccidioidomycosis acquired in Washington State. Clin Infect Dis. 2012;56(6):847–50.
Brillhante RS, Moreira Filho RE, Rocha MF, et al. Coccidioidomycosis in armadillo hunters from the state of Ceara, Brazil. Mem Inst Oswaldo Cruz. 2012;107(6):813–5.
Silva MB, Costa MM, Torres CC, et al. Urban sporotrichosis: a neglected epidemic in Rio de Janeiro, Brazil. Cad Saude Publica. 2012;28(10):1867–80.
Calanni LM, Perez R, Brasili S, et al. Outbreak of histoplasmosis in Province of Neuquen, Patagonia Argentina. Rev Iberoam Micol. 2012. doi:10.1016/j.riam.2012.12.007.
Pan B, Chen M, Pan W, Liao W. Histoplasmosis: a new endemic fungal infection in China? review and analysis of cases. Mycoses. 2013;56(3):212–21.
Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2013;175(1–2):57–67.
Neblett Fanfair R, Benedict K, Bos J, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–25.
• Cao C, Liang L, Wang W, et al. Common reservoirs for Penicillium marneffei infection in humans and rodents, China. Emerg Infect Dis. 2011;17(2):209–14. Very smart study with the aim of clarifying the physiopathology and natural cycle of P. marneffei.
Chandran V, Sadanandan SM, Sobhanakumari K. Chromoblastomycosis in Kerala, India. Indian J Dermatol Venereol Leprol. 2012;78(6):728–33.
Cordeiro Rde A, e Silva KR, Brilhante RS, et al. Coccidioides posadasii infection in bats, Brazil. Emerg Infect Dis. 2012;18(4):668–70.
Pal DK, Mallick AA, Majhi TK, Biswas BK, Chowdhury MK. Rhinosporidiosis in southwest Bengal. Trop Dr. 2012;42(3):150–3.
Apisarnthanarak A, Khawcharoenporn T, Thongphubeth K, et al. Postflood pseudofungemia due to Penicillium species. Clin Infect Dis. 2012;55(2):e9–e11.
Arantes TD, Theodoro RC, Da Graca Macoris SA, Bagagli E. Detection of Paracoccidioides spp. in environmental aerosol samples. Med Mycol. 2013;51(1):83–92.
Baddley JW, Winthrop KL, Patkar NM, et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis. 2011;17(9):1664–9.
Hassan HA, Majid RA, Rashid NG, et al. Eosinophilic granulomatous gastrointestinal and hepatic abscesses attributable to basidiobolomycosis and fasciolias: a simultaneous emergence in Iraqi Kurdistan. BMC Infect Dis. 2013;13:91.
Li AS, Pan WH, Wu SX, et al. Ecological surveys of the Cryptococcus species complex in China. Chin Med J (Engl). 2012;125(3):511–6.
Colom MF, Hagen F, Gonzalez A, et al. Ceratonia siliqua (carob) trees as natural habitat and source of infection by Cryptococcus gattii in the Mediterranean environment. Med Mycol. 2012;50(1):67–73.
Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, Meis JF. Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis. 2012;18(1):172–4.
Sellers B, Hall P, Cine-Gowdie S, et al. Cryptococcus gattii: an emerging fungal pathogen in the southeastern United States. Am J Med Sci. 2012;343(6):510–1.
Marr KA. Cryptococcus gattii as an important fungal pathogen of western North America. Expert Rev Anti-Infect Ther. 2012;10(6):637–43.
Marques-da-Silva SH, Rodrigues AM, de Hoog GS, Silveira-Gomes F, Camargo ZP. Occurrence of Paracoccidioides lutzii in the Amazon region: description of two cases. Am J Trop Med Hyg. 2012;87(4):710–4.
de Hoog GS, van Diepeningen AD, el Mahgoub S, van de Sande WW. New species of Madurella, causative agents of black-grain mycetoma. J Clin Microbiol. 2012;50(3):988–94.
Mhmoud NA, Ahmed SA, Fahal AH, de Hoog GS, Gerrits van den Ende AH, van de Sande WW. Pleurostomophora ochracea, a novel agent of human eumycetoma with yellow grains. J Clin Microbiol. 2012;50(9):2987–94.
Harris J, Lockhart S, Chiller T. Cryptococcus gattii: where do we go from here? Med Mycol. 2012;50(2):113–29.
Springer DJ, Phadke S, Billmyre B, Heitman J. Cryptococcus gattii, no longer an accidental pathogen? Curr Fungal Infect Rep. 2012;6(4):245–56.
Raffa RB, Eltoukhy NS, Raffa KF. Implications of climate change (global warming) for the healthcare system. J Clin Pharm Ther. 2012;37(5):502–4.
Bulterys PL, Le T, Quang VM, Nelson KE, Lloyd-Smith JO. Environmental predictors and incubation period of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Vietnam. Clin Infect Dis. 2013;56(9):1273–9.
Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis. 2012;54 Suppl 1:S35–43.
Weddle G, Gandy K, Bratcher D, Pahud B, Jackson MA. Apophysomyces trapeziformis infection associated with a tornado-related injury. Pediatr Infect Dis J. 2012;31(6):640–2.
Angelini A, Drago G, Ruggieri P. Post-tsunami primary Scedosporium apiospermum osteomyelitis of the knee in an immunocompetent patient. Int J Infect Dis. 2013;17(8):e646–9.
Oliveira GG, Navarro IT, Freire RL, et al. Serological survey of Paracoccidioidomycosis in sheep. Mycopathologia. 2012;173(1):63–8.
• Ngamskulrungroj P, Chang Y, Sionov E, Kwon-Chung KJ. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. MBio. 2012;3(3). Provides important insights in the pathogenesis of C. neoformans and C. gattii.
Trivedi SR, Sykes JE, Cannon MS, et al. Clinical features and epidemiology of cryptococcosis in cats and dogs in California: 93 cases (1988–2010). J Am Vet Med Assoc. 2011;239(3):357–69.
• McClelland EE, Hobbs LM, Rivera J, et al. The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS One. 2013;8(5):e63632. With reference 34, two interesting studies exploring the mechanisms of cryptococcal disease.
Bratton EW, El Husseini N, Chastain CA, et al. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One. 2012;7(8):e43582.
Fierer J, Burton DW, Haghighi P, Deftos LJ. Hypercalcemia in disseminated coccidioidomycosis: expression of parathyroid hormone-related peptide is characteristic of granulomatous inflammation. Clin Infect Dis. 2012;55(7):e61–6.
Abreu e Silva MA, Salum FG, Figueiredo MA, Cherubini K. Important aspects of oral paracoccidioidomycosis – a literature review. Mycoses. 2013;56(3):189–99.
Azenha MR, Caliento R, Brentegani LG, de Lacerda SA. A retrospective study of oral manifestations in patients with paracoccidioidomycosis. Braz Dent J. 2012;23(6):753–7.
de Abreu ESMA, Salum FG, Figueiredo MA, Lopes TG, da Silva VD, Cherubini K. Interrelationship of clinical, histomorphometric and immunohistochemical features of oral lesions in chronic paracoccidioidomycosis. J Oral Pathol Med. 2013;42(3):235–42.
Agudelo CA, Restrepo CA, Molina DA, et al. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012;87(6):1094–8.
Shahani L. Disseminated histoplasma and CMV infection presenting as subacute intestinal obstruction in an immunocompromised patient. BMJ Case Rep. 2012;2012.
Lee PP, Chan KW, Lee TL, et al. Penicilliosis in children without HIV infection – are they immunodeficient? Clin Infect Dis. 2012;54(2):e8–e19.
Geramizadeh B, Foroughi R, Keshtkar-Jahromi M, Malek-Hosseini SA, Alborzi A. Gastrointestinal basidiobolomycosis, an emerging infection in the immunocompetent host: a report of 14 patients. J Med Microbiol. 2012;61(Pt 12):1770–4.
Brick KE, Drolet BA, Lyon VB, Galbraith SS. Cutaneous and disseminated blastomycosis: a pediatric case series. Pediatr Dermatol. 2013;30(1):23–8.
Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol. 2012;50(5):1783–6.
Van Der Veer J, Lewis RJ, Emtiazjoo AM, Allen SD, Wheat LJ, Hage CA. Cross-reactivity in the Platelia aspergillus enzyme immunoassay caused by blastomycosis. Med Mycol. 2012;50(4):396–8.
Thompson 3rd GR, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA. Serum (1->3)-beta-D-glucan measurement in coccidioidomycosis. J Clin Microbiol. 2012;50(9):3060–2.
Thompson GR, Sharma S, Bays DJ, et al. Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest. 2013;143(3):776–81.
Espinel-Ingroff A, Aller AI, Canton E, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother. 2012;56(11):5898–906.
Posteraro B, Vella A, Cogliati M, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii. J Clin Microbiol. 2012;50(7):2472–6.
Koepsell SA, Hinrichs SH, Iwen PC. Applying a real-time PCR assay for Histoplasma capsulatum to clinically relevant formalin-fixed paraffin-embedded human tissue. J Clin Microbiol. 2012;50(10):3395–7.
Riviere S, Denis B, Bougnoux ME, Lanternier F, Lecuit M, Lortholary O. Serum Aspergillus galactomannan for the management of disseminated histoplasmosis in AIDS. Am J Trop Med Hyg. 2012;87(2):303–5.
Vergidis P, Walker RC, Kaul DR, et al. False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis. Transpl Infect Dis. 2012;14(2):213–7.
Millon L, Larosa F, Lepiller Q, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013;56(10):e95–e101.
El Shamy ME, Fahal AH, Shakir MY, Homeida MM. New MRI grading system for the diagnosis and management of mycetoma. Trans R Soc Trop Med Hyg. 2012;106(12):738–42.
Bertoni TA, Perenha-Viana MC, Patussi EV, Cardoso RF, Svidzinski TI. Western blotting is an efficient tool for differential diagnosis of paracoccidioidomycosis and pulmonary tuberculosis. Clin Vaccine Immunol. 2012;19(11):1887–8.
Dias L, de Carvalho LF, Romano CC. Application of PCR in serum samples for diagnosis of paracoccidioidomycosis in the southern Bahia-Brazil. PLoS Negl Trop Dis. 2012;6(11):e1909.
Lackner M, de Hoog GS, Verweij PE, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 2012;56(5):2635–42.
Liu X, Zhang Z, Hou B, et al. Rapid identification of Sporothrix schenckii in biopsy tissue by PCR. J Eur Acad Dermatol Venereol. 2012. doi:10.1111/jdv.12030.
Huang JY, Bristow B, Shafir S, Sorvillo F. Coccidioidomycosis-associated deaths, United States, 1990–2008. Emerg Infect Dis. 2012;18(11):1723–8.
Seitz AE, Prevots DR, Holland SM. Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA. Emerg Infect Dis. 2012;18(9):1476–9.
Azadeh N, Chang YH, Kusne S, et al. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis. J Infect. 2013;67(2):148–55.
Levy ER, McCarty JM, Shane AL, Weintrub PS. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Clin Infect Dis. 2013;56(11):1573–8.
Taroumian S, Knowles SL, Lisse JR, et al. Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs. Arthritis Care Res (Hoboken). 2012;64(12):1903–9.
Proia LA, Harnisch DO. Successful use of posaconazole for treatment of blastomycosis. Antimicrob Agents Chemother. 2012;56(7):4029.
Brilhante RS, Caetano EP, Sidrim JJ, et al. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii. Mycoses. 2013;56(3):397–401.
Kloezen W, Meis JF, Curfs-Breuker I, Fahal AH, van de Sande WW. In vitro antifungal activity of isavuconazole against Madurella mycetomatis. Antimicrob Agents Chemother. 2012;56(11):6054–6.
van Belkum A, Fahal AH, van de Sande WW. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine. Antimicrob Agents Chemother. 2011;55(4):1771–3.
Compliance with Ethics Guidelines
Conflict of Interest
C. Richaud was supported in 2011 by a grant from Novartis.
D. Lebeaux was supported by a grant from the AXA research fund.
O. Lortholary is a member of the Merck Sharp & Dohme (MSD) board, is a consultant for Astellas and Gilead Sciences, and received speaker’s fees from MSD, Astellas, Gilead Sciences, and Pfizer.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Richaud, C., Lebeaux, D. & Lortholary, O. Fungal Infections Associated with Travel. Curr Fungal Infect Rep 7, 311–319 (2013). https://doi.org/10.1007/s12281-013-0151-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12281-013-0151-0